January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

December 18, 2014

Dr. Reddy’s Laboratories announced Tuesday that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of the antiviral Valcyte (Valganciclovir) tablets, in the U.S. market.

December 18, 2014

Iodine, developer of health information website Iodine.com, on Wednesday launched a new Web app for cold and flu season.

December 17, 2014

Skin care company Adovia has debuted its new Natural Sulfur Soap enriched with minerals and sulfur from the Dead Sea.

December 16, 2014

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

December 16, 2014

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

December 16, 2014

Use of cigarettes, alcohol and abuse of prescription pain relievers among teens has declined since 2013, while marijuana use rates were stable, according to the 2014 Monitoring the Future survey, released Tuesday.

December 11, 2014

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg. 

December 11, 2014

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

December 10, 2014

Between 2013 and 2020, there is the possibility of more than $12 billion in healthcare cost savings if women older than 55 years were to take with calcium and vitamin D supplements, the Council for Responsible Nutrition revealed in a release issued Tuesday.

December 9, 2014

BioPharmX on Tuesday announced the availability of Violet iodine, a new once-daily supplement for relief of premenstrual breast discomfort.

December 9, 2014

The Generic Pharmaceutical Association agreed to support compromise automatic substitution legislation.

December 9, 2014

From 2009 to 2013, the number of Americans using prescription opiates declined 9.2%, yet both the number of opioid prescriptions filled and the number of days of medication per prescription rose more than 8% in that time period. 

December 9, 2014

Teva Canada, a subsidiary of Teva Pharmaceutical Industries, announced Tuesday that Health Canada has approved its application for the generic version of PrTarceva. 

December 8, 2014
Kroger and Medicine Shoppe are participating in MediMergent's pilot study of the National Medication Safety, Outcomes and Adherence Program.
December 8, 2014

The pros of giving healthy women regular low dose aspirin to stave off such serious illness as cancer and heart disease are outweighed by the cons, suggests a large study published online last week in the journal Heart.

December 8, 2014

President Barack Obama signed into law in late November the Sunscreen Innovation Act.

December 4, 2014

Camber Pharmaceuticals announced the addition of montelukast sodium tablets to its portfolio of products.

December 4, 2014

Diplomat Pharmacy announced Wednesday that it has been selected to Pfizer's limited-distribution panel for Xalkori, Bosulif, Inlyta and Sutent.

December 3, 2014

Thompson Brands on Tuesday announced the launch of an improved formula for its Adora Calcium Supplement.

December 2, 2014

Teva Pharmaceuticals on Monday announced the introduction and availability of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, CIII.

December 1, 2014

NACDS advocated for the voluntary ability of pharmacies to extend their reward and loyalty programs to beneficiaries in government programs.

December 1, 2014

Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States. 

November 25, 2014

Mylan on Tuesday confirmed that it — along with several subsidiaries — has been sued by Baxter International, Baxter Healthcare Corp. and Baxter Healthcare S.A. in relation to the filing of an abbreviated new drug application for the generic version of Brevibloc.